Isoprinosine: lack of antiviral activity in experimental model infections.

Authors:
Glasgow LA; Galasso GJ.

Journal:
J Infect Dis

Publication Year: 1972

DOI:
10.1093/infdis/126.2.162

PMCID:
PMC7110087

PMID:
4340925

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Infect Dis

Abbreviation: J Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accumulation of Immunity in Heavy-Tailed Sexual Contact Networks Shapes Mpox Outbreak Sizes.
Murayama H; Pearson CAB; Abbott S and 5 more (2024) - Transparency Score: 4/6
A Phase 2 Extension Study Evaluating the Immunogenicity, Safety, and Tolerability of 3 or 4 Doses o…
Remich S; Kitchin N; Peterson J and 8 more (2024) - Transparency Score: 4/6
COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients Wi…
Kanberg N; Grahn A; Stentoft E and 19 more (2024) - Transparency Score: 3/6
Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnan…
Adhikari EH; Lu P; Kang YJ and 7 more (2024) - Transparency Score: 3/6
Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resista…
Chou S; Alain S; Cervera C and 9 more (2024) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"This research was supported by grants no. NIH-702131, NIH-70-2133, NIH-70-2175, NIH-70-2130, and NIH-70-2132 from the National Institute of Allergy and Infectious Diseases. Complete reports on the individual studies are available through the National Technical Information Service, U. S. Department of Commerce, 5285 Part Royal Road, Springfield, Virginia 22151, as part of the required annual report on all contracts sponsored by NIH."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025